11 Sep Section 36 approval – KLACID XL
Posted at 13:49h
in
The DHCPL is intended to inform healthcare professionals that Abbott Labs is experiencing a delay in production from the manufacturing site and anticipates shortages of Klacid XL in emerging markets.
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
04/09/2023
File Type:
pdf
Category:
Communication To Health Care Professionals